Commercial Bank of Dubai PSC

DFM:CBD Stock Report

Market Cap: د.إ21.1b

Commercial Bank of Dubai PSC Valuation

Is CBD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CBD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CBD's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CBD's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CBD?

Key metric: As CBD is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CBD. This is calculated by dividing CBD's market cap by their current earnings.
What is CBD's PE Ratio?
PE Ratio7.5x
Earningsد.إ2.81b
Market Capد.إ21.08b

Price to Earnings Ratio vs Peers

How does CBD's PE Ratio compare to its peers?

The above table shows the PE ratio for CBD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average7.4x
EIB Emirates Islamic Bank PJSC
9.1xn/aد.إ27.2b
RAKBANK National Bank of Ras Al-Khaimah (P.S.C.)
5.4x-1.9%د.إ11.4b
ADIB Abu Dhabi Islamic Bank PJSC
8.5x4.6%د.إ46.5b
DIB Dubai Islamic Bank P.J.S.C
6.7x-3.4%د.إ47.0b
CBD Commercial Bank of Dubai PSC
7.5x2.9%د.إ21.1b

Price-To-Earnings vs Peers: CBD is expensive based on its Price-To-Earnings Ratio (7.5x) compared to the peer average (7.4x).

Price to Earnings Ratio vs Industry

How does CBD's PE Ratio compare vs other companies in the Asian Banks Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CBD 7.5xIndustry Avg. 8.4xNo. of Companies79PE0612182430+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CBD is good value based on its Price-To-Earnings Ratio (7.5x) compared to the Asian Banks industry average (8.4x).

Price to Earnings Ratio vs Fair Ratio

What is CBD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CBD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio7.5x
Fair PE Ratio7.5x

Price-To-Earnings vs Fair Ratio: CBD is expensive based on its Price-To-Earnings Ratio (7.5x) compared to the estimated Fair Price-To-Earnings Ratio (7.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CBD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentد.إ7.06
د.إ7.05
-0.09%
16.2%د.إ8.50د.إ5.70n/a3
Nov ’25د.إ7.60
د.إ7.05
-7.2%
16.2%د.إ8.50د.إ5.70n/a3
Oct ’25د.إ6.53
د.إ7.05
+8.0%
16.2%د.إ8.50د.إ5.70n/a3
Sep ’25د.إ6.29
د.إ7.05
+12.1%
16.2%د.إ8.50د.إ5.70n/a3
Aug ’25د.إ6.45
د.إ7.05
+9.4%
16.2%د.إ8.50د.إ5.70n/a3
Jul ’25د.إ6.40
د.إ6.79
+6.0%
21.7%د.إ8.50د.إ4.90n/a3
Jun ’25د.إ6.01
د.إ6.79
+12.9%
21.7%د.إ8.50د.إ4.90n/a3
May ’25د.إ6.53
د.إ6.79
+3.9%
21.7%د.إ8.50د.إ4.90n/a3
Apr ’25د.إ6.97
د.إ6.34
-9.0%
24.5%د.إ8.50د.إ4.90n/a3
Mar ’25د.إ8.16
د.إ5.91
-27.6%
16.2%د.إ7.20د.إ4.90n/a3
Feb ’25د.إ5.60
د.إ5.91
+5.5%
16.2%د.إ7.20د.إ4.90n/a3
Jan ’25د.إ5.11
د.إ5.91
+15.7%
16.2%د.إ7.20د.إ4.90n/a3
Dec ’24د.إ4.79
د.إ5.91
+23.4%
16.2%د.إ7.20د.إ4.90n/a3
Nov ’24د.إ4.70
د.إ5.88
+25.0%
16.9%د.إ7.20د.إ4.80د.إ7.603
Oct ’24د.إ4.75
د.إ5.88
+23.7%
16.9%د.إ7.20د.إ4.80د.إ6.533
Sep ’24د.إ4.70
د.إ5.88
+25.0%
16.9%د.إ7.20د.إ4.80د.إ6.293
Aug ’24د.إ4.72
د.إ5.88
+24.5%
16.9%د.إ7.20د.إ4.80د.إ6.453
Jul ’24د.إ4.54
د.إ5.86
+29.1%
13.5%د.إ6.80د.إ4.69د.إ6.404
Jun ’24د.إ4.60
د.إ5.83
+26.7%
13.3%د.إ6.80د.إ4.69د.إ6.014
May ’24د.إ4.45
د.إ5.67
+27.4%
10.7%د.إ6.20د.إ4.69د.إ6.534
Apr ’24د.إ4.15
د.إ5.74
+38.3%
11.7%د.إ6.48د.إ4.69د.إ6.974
Mar ’24د.إ4.79
د.إ5.60
+17.0%
13.0%د.إ6.48د.إ4.69د.إ8.163
Feb ’24د.إ4.65
د.إ5.48
+17.8%
13.6%د.إ6.48د.إ4.69د.إ5.603
Jan ’24د.إ4.53
د.إ5.54
+22.2%
13.2%د.إ6.48د.إ4.69د.إ5.113
Dec ’23د.إ4.36
د.إ5.45
+25.1%
11.4%د.إ6.22د.إ4.69د.إ4.793
Nov ’23د.إ4.60
د.إ5.58
+21.2%
8.5%د.إ6.22د.إ5.07د.إ4.703

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies